{
    "2019-09-18": [
        [
            {
                "time": "2019-09-13",
                "original_text": "Novartis halts distribution of generic heartburn medication",
                "features": {
                    "keywords": [
                        "Novartis",
                        "halts",
                        "distribution",
                        "generic",
                        "heartburn"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-13",
                "original_text": "Distribution of heartburn drug Zantac halted over possible carcinogen",
                "features": {
                    "keywords": [
                        "Distribution",
                        "halted",
                        "heartburn",
                        "drug",
                        "Zantac",
                        "possible",
                        "carcinogen"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-13",
                "original_text": "ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
                "features": {
                    "keywords": [
                        "ONGOING",
                        "INVESTIGATION",
                        "Schall",
                        "Law",
                        "Firm",
                        "Investigating",
                        "Claims",
                        "Novartis",
                        "AG",
                        "Investors",
                        "Losses"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "legal",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-13",
                "original_text": "Novartis halts distribution of its Zantac versions amid probe into impurities",
                "features": {
                    "keywords": [
                        "Novartis",
                        "halts",
                        "distribution",
                        "Zantac",
                        "versions",
                        "probe",
                        "impurities"
                    ],
                    "sentiment_score": -0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-13",
                "original_text": "After Boston speech, Ex-FDA chief defends record on vaping in interview",
                "features": {
                    "keywords": [
                        "Boston",
                        "speech",
                        "Ex-FDA",
                        "chief",
                        "defends",
                        "record",
                        "vaping",
                        "interview"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "regulation"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}